• Product name
    Anti-NETO2 antibody [EPR3497]
    See all NETO2 primary antibodies
  • Description
    Rabbit monoclonal [EPR3497] to NETO2
  • Host species
  • Tested applications
    Suitable for: WB, IPmore details
    Unsuitable for: Flow Cyt,ICC or IHC-P
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide within Human NETO2 aa 500-600. The exact sequence is proprietary.

  • Positive control
    • Human cerebellum, SH-SY5Y and Human brain lysates; Mouse and Rat brain lysates.
  • General notes



    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents

    We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

    This product is a recombinant rabbit monoclonal antibody.


  • Form
  • Storage instructions
    Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage buffer
    pH: 7.20
    Preservative: 0.05% Sodium azide
    Constituents: 0.1% BSA, 40% Glycerol, 9.85% Tris glycine, 50% PBS
  • Concentration information loading...
  • Purity
    Protein A purified
  • Clonality
  • Clone number
  • Isotype
  • Research areas


Our Abpromise guarantee covers the use of ab109288 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 60 kDa.
IP 1/10 - 1/100.
  • Application notes
    Is unsuitable for Flow Cyt,ICC or IHC-P.
  • Target

    • Function
      Accessory subunit of neuronal kainate-sensitive glutamate receptors, GRIK2 and GRIK3. Increases kainate-receptor channel activity, slowing the decay kinetics of the receptors, without affecting their expression at the cell surface, and increasing the open probability of the receptor channels. Modulates the agonist sensitivity of kainate receptors. Slows the decay of kainate receptor-mediated excitatory postsynaptic currents (EPSCs), thus directly influencing synaptic transmission.
    • Sequence similarities
      Contains 2 CUB domains.
      Contains 1 LDL-receptor class A domain.
    • Post-translational
    • Cellular localization
    • Information by UniProt
    • Database links
    • Alternative names
      • Brain specific transmembrane protein antibody
      • Brain specific transmembrane protein containing 2 CUB and 1 LDL receptor class A domains protein 2 antibody
      • Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2 antibody
      • BTCL2 antibody
      • FLJ10430 antibody
      • FLJ14724 antibody
      • FLJ90456 antibody
      • NEOT2 antibody
      • NETO 2 antibody
      • Neto2 antibody
      • NETO2_HUMAN antibody
      • Neuropilin (NRP) and tolloid (TLL) like 2 antibody
      • Neuropilin and tolloid like protein 2 antibody
      • Neuropilin and tolloid-like protein 2 antibody
      see all


    • All lanes : Anti-NETO2 antibody [EPR3497] (ab109288) at 1/1000 dilution

      Lane 1 : Human cerebellum lysates
      Lane 2 : SH-SY5Y cell lysates
      Lane 3 : Human brain lysates

      Lysates/proteins at 10 µg per lane.

      Predicted band size: 60 kDa

    • All lanes : Anti-NETO2 antibody [EPR3497] (ab109288) at 1/1000 dilution

      Lane 1 : mouse brain lysates
      Lane 2 : rat brain lysates

      Lysates/proteins at 10 µg per lane.

      Predicted band size: 60 kDa


    This product has been referenced in:
    • Vernon CG & Swanson GT Neto2 assembles with kainate receptors in DRG neurons during development and modulates neurite outgrowth in adult sensory neurons. J Neurosci N/A:N/A (2017). WB . Read more (PubMed: 28235897) »
    • Hu L  et al. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma. BMC Cancer 15:1006 (2015). WB ; Human . Read more (PubMed: 26699544) »

    See all 2 Publications for this product

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab109288.
    Please use the links above to contact us or submit feedback about this product.


    Sign up